Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

215

Participants

Timeline

Start Date

August 19, 2015

Primary Completion Date

November 9, 2016

Study Completion Date

November 14, 2016

Conditions
Plaque Psoriasis
Interventions
DRUG

IDP-118 Lotion

Lotion

DRUG

IDP-118 Vehicle Lotion

Lotion

Trial Locations (16)

10001

Valeant Site 12, New York

27260

Valeant Site 6, High Point

33160

Valeant Site 14, North Miami Beach

33424

Valeant Site 2, Boynton Beach

37909

Valeant Site 7, Knoxville

48088

Valeant Site 8, Warren

48201

Valeant Site 13, Detroit

55421

Valeant Site 10, Fridley

77001

Valeant Site 15, Houston

Valeant Site 16, Houston

77840

Valeant Site 9, College Station

78660

Valeant Site 11, Pflugerville

87103

Valeant Site 4, Albuquerque

94536

Valeant Site 5, Fremont

97201

Valeant Site 3, Portland

08520

Valeant Site 1, East Windsor

Sponsors
All Listed Sponsors
collaborator

Dow Pharmaceutical Sciences

INDUSTRY

lead

Bausch Health Americas, Inc.

INDUSTRY